Literature DB >> 19767655

The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.

Helois E Radford1, Giovanna R Mallucci.   

Abstract

There are two central phenomena in prion disease: prion replication and prion neurotoxicity. Underlying them both is the conversion of a host-encoded ubiquitously expressed protein, prion protein (PrP(C)), into a partially-protease resistant isoform, PrP(Sc), which accumulates in the brain. PrP(Sc) is associated with both pathology and infectivity. In the absence of PrP(C), PrP(Sc) cannot be generated and PrP-null mice do not propagate infectivity or develop pathology on infection with scrapie. However, while PrP(C) expression is fundamental to both prion infectivity and neurodegeneration, the uncoupling of these processes is a growing concept in the field. This dissociation is evident in subclinical states of prion infection, where PrP(Sc) levels are high in the absence of disease, and in transgenic mice experiments, where, despite extra-neuronal PrP(Sc) accumulation, even in very high amounts, there is no neurotoxicity. Both these models have further implications. Thus depleting PrP(C) from neurons (but not glia) of prion-infected mice prevents clinical disease, and detaching it from the surface of cells by removing its anchor does the same. The uncoupling toxicity and infectivity has implications for the nature of the neurotoxic species; these mouse models suggest that the site for the generation of this species is intra-neuronal. This review considers the role of neuronal surface-expressed PrP(C) in mediating toxicity in prion infection, and the dissociation of this from the deposition of PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767655

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  13 in total

1.  Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.

Authors:  Xu Qi; Roger A Moore; Michele A McGuirl
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

2.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

3.  Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Authors:  Ajay Singh; Liuting Qing; Qingzhong Kong; Neena Singh
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

4.  Conditional modulation of membrane protein expression in cultured cells mediated by prion protein recognition of short phosphorothioate oligodeoxynucleotides.

Authors:  Marcela Viviana Karpuj; Sagit Gelibter-Niv; Anat Tiran; Angelika Rambold; Jörg Tatzelt; Max Nunziante; Hermann M Schatzl
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

Review 5.  The prion hypothesis: from biological anomaly to basic regulatory mechanism.

Authors:  Mick F Tuite; Tricia R Serio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11-17       Impact factor: 94.444

6.  Prions and neuronal death.

Authors:  G Di Guardo; G Marruchella
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

Review 7.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

8.  Drosophila GPI-mannosyltransferase 2 is required for GPI anchor attachment and surface expression of chaoptin.

Authors:  Erica E Rosenbaum; Kimberley S Brehm; Eva Vasiljevic; Allen Gajeski; Nansi Jo Colley
Journal:  Vis Neurosci       Date:  2012-05-10       Impact factor: 3.241

9.  Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity.

Authors:  Young Jin Lee; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

10.  Amyloid-associated activity contributes to the severity and toxicity of a prion phenotype.

Authors:  John A Pezza; Janice Villali; Suzanne S Sindi; Tricia R Serio
Journal:  Nat Commun       Date:  2014-07-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.